1. Home
  2. Live Updates
  3. Upstream bio

Live Breaking News & Updates on Upstream Bio

Stay updated with breaking news from Upstream bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HBM Healthcare Investments publishes Quarterly Report as at 31 December 2023 with key figures for the first nine months of the 2023/2024 financial year

HBM Healthcare Investments publishes Quarterly Report as at 31 December 2023 with key figures for the first nine months of the 2023/2024 financial year
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Arrivent Biopharma , Ambrx Biopharma , Longboard Pharmaceuticals , Chinook Therapeutics , Prometheus Biosciences , Cathay Biotech , Mineralys Therapeutics , Odyssey Therapeutics , Upstream Bio , Quarterly Report December ,

HBM Healthcare Investments publishes Quarterly Report as at 31 December 2023 with key figures for the first nine months of the 2023/2024 financial year - adhoc - Börsennachrichten

HBM Healthcare Investments AG Key word Quarter Results HBM Healthcare Investments publishes Quarterly Report as at 31 December 2023 with key figures for the first nine months of the 20232024 financia ....

Arrivent Biopharma , Ambrx Biopharma , Longboard Pharmaceuticals , Chinook Therapeutics , Prometheus Biosciences , Cathay Biotech , Mineralys Therapeutics , Odyssey Therapeutics , Upstream Bio , Quarterly Report December ,

GSK to buy asthma drug startup Aiolos for $1B

BioPharma ....

San Francisco , United States , City Of , United Kingdom , Khurem Farooq , Aiolos Bio , Jiangsu Hengrui , Tony Wood , Drug Administration , Merck Co , Atlas Venture , China Jiangsu Hengrui Pharmaceuticals , Bain Capital Life Sciences , Bain Capital Life , October Aiolos , Gyroscope Therapeutics , Healthcare Conference , Scientific Officer Tony Wood , Upstream Bio ,

Upstream Bio Announces Dosing of First Patients in a Phase 2 Clinical Trial of Verekitug (UPB-101) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Upstream Bio Announces Dosing of First Patients in a Phase 2 Clinical Trial of Verekitug (UPB-101) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United States , Sam Truex , Aaron Deykin , American Lung Association , Product Service , Head Of Research , Bio Announces Dosing , First Patients , Chronic Rhinosinusitis , Nasal Polyps , Chief Medical Officer , Upstream Bio , Chief Executive , Stromal Lymphopoietin , Lung Association ,

OrbiMed raises $4.3B in new funds for startup investing

BioPharma ....

Hong Kong , City Of , United Kingdom , Carter Neild , New York Based , Orbimed Private Investments , Orbimed Royalty , Star Therapeutics , Upstream Bio , Rampart Bio ,